Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 9/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.47 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 5/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2298722 | 0.93 | CYP2C9 (0.50) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL2298288 | 0.91 | CYP2C9 (0.46) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL2297014 | 0.91 | CYP2C9 (0.46) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL14697724 | 0.87 | CYP2C9 (0.51) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL2297180 | 0.87 | CYP3A4 (0.51) | CYP3A4CYP2C9CYP2C19KCNH2CYP2C8 | |
| SCHEMBL2296829 | 0.87 | CYP2C9 (0.52) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL14697709 | 0.85 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL2295644 | 0.85 | CYP2C9 (0.49) | CYP3A4CYP2C9CYP2C19KCNH2WDR5 | |
| SCHEMBL2297799 | 0.84 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL2302055 | 0.84 | CYP2C9 (0.56) | CYP3A4CYP2C9CYP2C19KCNH2CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011103063-A1 | THERAPEUTIC COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2011-08-25 | — | — | WO | disclosed |